Abstract

Vicharchika is described in Ayurveda as a Kshudra Kushtha with prominent itching, eruptions, exudation, and altered colour. This symptom pattern often resembles eczematous dermatitis, yet neither term represents a precise translation of the other. Contemporary eczema, particularly atopic dermatitis, includes distinct barrier, immune, microbial, and neural abnormalities. Objective: To critically relate the classical disease model of Vicharchika to current knowledge of eczema and to examine how Ayurvedic and modern treatments can be evaluated without forcing direct biological equivalence between the two systems. Approach: Classical descriptions and published clinical studies of Ayurvedic interventions were interpreted alongside established research on epidermal barrier failure, type-2 inflammation, neuroimmune pruritus, JAK-STAT signalling, skin microbiota, and contemporary treatment. The review uses conceptual comparison rather than literal translation of Ayurvedic terms into cytokines or molecular pathways. Synthesis: Dosha involvement, disturbance of Twak and Rakta, altered Agni, and continuing exposure to Nidana provide the classical framework. Modern research describes a self-reinforcing relationship among barrier injury, immune activation, scratching, and microbial imbalance. Ayurvedic treatment studies involving Virechana, Raktamokshana, topical therapy, and Rasayana report symptomatic benefit, but small samples and variable methods limit certainty. Integrative investigation should retain standard dermatological care, define the Ayurvedic intervention precisely, and measure severity, itch, quality of life, barrier function, recurrence, and safety. Conclusion: The most defensible relationship between Vicharchika and eczema is one of clinical overlap, not diagnostic identity. Ayurvedic treatment remains promising for research, but reliable conclusions require standardized products and procedures, controlled designs, validated outcome measures, and longer follow-up.